NCLEX-RN • Physiological Integrity

Acute Stroke: Priority Actions And Care — Acute Stroke: Priority Actions And Time-Sensitive Care

Rapid recognition and time-critical interventions determine neurological outcomes in acute stroke management.

A stethoscope, heartbeat, and checked clinical chart representing the nursing licensure exam.
Inside this lesson 10 sections 5 questions 7 figures

SECTION 1

Historical Context & Motivation

For most of medical history, stroke was considered a devastating but essentially untreatable event. Clinicians could observe patients losing speech, motor function, or consciousness, yet the prevailing medical paradigm offered little beyond supportive care and long-term rehabilitation. The concept that acute stroke could be treated as a medical emergency—much like a myocardial infarction—did not gain traction until the latter half of the twentieth century. This paradigm shift was driven by advances in neuroimaging, thrombolytic therapy, and a growing understanding of the ischemic penumbra, the region of salvageable brain tissue surrounding the infarct core. Today, the phrase "time is brain" encapsulates the urgency of acute stroke management, reminding nurses and providers alike that approximately 1.9 million neurons are lost every minute a large-vessel ischemic stroke goes untreated.

1928 • Early Stroke Classification

Charles Foix and colleagues publish seminal work correlating vascular territories with clinical stroke syndromes, laying the groundwork for understanding that different arteries produce distinct neurological deficits.

1970s • CT Imaging Revolution

The introduction of computed tomography allows clinicians to distinguish ischemic stroke from hemorrhagic stroke in living patients for the first time, a distinction critical for treatment decisions.

1995 • NINDS rt-PA Trial

The landmark NINDS trial demonstrates that intravenous alteplase (rt-PA) administered within 3 hours of ischemic stroke symptom onset significantly improves outcomes, ushering in the era of acute stroke treatment.

2015 • Endovascular Thrombectomy Trials

Five major randomized controlled trials (MR CLEAN, ESCAPE, EXTEND-IA, SWIFT PRIME, REVASCAT) conclusively demonstrate the benefit of mechanical thrombectomy for large-vessel occlusion strokes, extending the treatment window significantly.

2018–Present • Extended Time Windows

The DAWN and DEFUSE 3 trials expand the thrombectomy window to up to 24 hours in select patients using advanced perfusion imaging, while alteplase guidelines now extend to 4.5 hours for eligible patients.

This historical trajectory reveals a fundamental question that defines modern stroke nursing: How can the bedside nurse rapidly identify stroke, initiate the correct protocol, and ensure time-sensitive interventions are delivered within their narrow therapeutic windows? The answer requires mastery of rapid assessment tools, an understanding of the pathophysiology driving treatment urgency, and familiarity with the protocols that govern acute stroke care in the emergency department and beyond.

SECTION 2

Core Principles of Acute Stroke Care

Effective acute stroke management rests on a set of foundational principles that guide every clinical decision from the moment a patient presents with neurological symptoms. These principles integrate pathophysiological understanding with evidence-based protocols, ensuring that nurses can function as decisive members of the stroke team. Each principle reinforces the overarching theme that rapid, systematic action directly correlates with preserved neurological function and reduced morbidity.

1

Time Is Brain

Every minute of untreated large-vessel ischemic stroke destroys approximately 1.9 million neurons. Treatment efficacy declines exponentially with each passing hour, making rapid identification and intervention the single greatest determinant of patient outcomes.
2

Differentiate Stroke Types

Ischemic strokes (approximately 87% of cases) and hemorrhagic strokes require fundamentally different interventions. Neuroimaging (CT or MRI) must be obtained before any thrombolytic therapy to rule out hemorrhage, as administering alteplase to a hemorrhagic stroke patient can be fatal.
3

Systematic Rapid Assessment

Standardized screening tools—including the Cincinnati Prehospital Stroke Scale, the NIH Stroke Scale (NIHSS), and the BE-FAST mnemonic—enable rapid, reproducible identification and severity grading of stroke presentations.
4

Neuroprotective Nursing Priorities

Beyond thrombolytics, nurses maintain airway patency, hemodynamic stability, glycemic control, normothermia, and head-of-bed positioning to minimize secondary brain injury and optimize perfusion to the ischemic penumbra.
5

Collaborative Protocol Activation

Stroke care is inherently team-based. The nurse activates the stroke code, coordinates with radiology for emergent imaging, communicates with pharmacy for thrombolytic preparation, and ensures the stroke neurologist is engaged—all within a target of 10 minutes from door to physician assessment.
✦

KEY TAKEAWAY

Think of acute stroke care like responding to a house fire. The ischemic penumbra is the room next to the fire—it has not yet burned, but it will if the fire department (your stroke team) does not arrive quickly. Every protocol in acute stroke care is designed to save that room. The CT scan is the fire assessment (what type of fire?), alteplase is the water hose (dissolving the clot), and your nursing interventions—airway management, blood pressure control, positioning—are the firebreaks that prevent the fire from spreading. Without rapid, systematic action, the salvageable tissue is lost permanently.

SECTION 3

Acute Stroke Assessment & Time-Critical Pathway

The following diagram illustrates the acute stroke care pathway from symptom onset through definitive treatment. Understanding this timeline is essential for NCLEX preparation because it contextualizes the nursing priority actions within their time-critical windows. The door-to-needle time target of 60 minutes or less for IV alteplase administration represents a nationally benchmarked quality metric, and the nurse's role in achieving this benchmark begins the moment the patient crosses the emergency department threshold.

ACUTE STROKE CARE TIMELINE — DOOR TO TREATMENT0 min10 min25 min45 min60 minDOOR (0–10 min)• ABCs / Vital signs• Activate stroke code• IV access / Labs / BG• NIHSS assessmentIMAGING (10–25 min)• Non-contrast CT head• CT angiography (CTA)• Rule out hemorrhage• Interpret results STATDECISION (25–45 min)• Review inclusion/exclusion• Consent for alteplase• Mix thrombolytic• Weigh patient accuratelyTREAT (≤60 min)• IV alteplase bolus + drip• Monitor for hemorrhage• Neuro checks q15min• BP per protocolNURSING PRIORITY ACTIONS AT EACH PHASEISCHEMIC STROKE PATHWAY1. IV alteplase within 3–4.5 hr of symptom onset2. Mechanical thrombectomy for LVO (up to 24 hr)3. BP ≤185/110 before alteplase; ≤180/105 after4. No antiplatelets/anticoagulants for 24 hr post rt-PA5. NPO until dysphagia screen completedHEMORRHAGIC STROKE PATHWAY1. NO thrombolytics — absolute contraindication2. Reverse anticoagulants if applicable3. Aggressive BP control (SBP <140 mmHg)4. Neurosurgical consult for evacuation5. ICP monitoring / managementCRITICAL NURSING REMINDERS✦"Last known well" time is more important than onset time✦Only glucose must result before alteplase — do NOT wait for other labs✦Any neurological decline during alteplase → STOP infusion → STAT CT
This pathway shows the four critical phases from door to treatment, with a target of 60 minutes door-to-needle time. Note the divergent pathways for ischemic versus hemorrhagic stroke after imaging, and the critical nursing reminders applicable to both.

As depicted in the diagram, the nurse's actions during the first 10 minutes are decisive. Establishing intravenous access, drawing blood for a point-of-care glucose (hypoglycemia can mimic stroke), activating the stroke code, and initiating the NIH Stroke Scale (NIHSS) assessment all occur simultaneously with the initial ABCs. The NIHSS score not only quantifies deficit severity (0 = no deficit; 42 = maximum deficit) but also helps the stroke team determine candidacy for interventions. A critical point visible in the diagram is that only the blood glucose result must return before alteplase can be administered—the nurse should not delay thrombolytic administration waiting for complete lab panels, as this directly undermines the door-to-needle benchmark.

SECTION 4

Pathophysiology Driving Time-Sensitive Interventions

Understanding why stroke care is time-sensitive requires an appreciation of the underlying pathophysiology. In ischemic stroke, a thrombus or embolus occludes a cerebral artery, abruptly halting blood flow to a defined vascular territory. Within the center of this territory, cells die within minutes due to complete ischemia—this is the infarct core. Surrounding the core, however, lies the ischemic penumbra—a region of hypoperfused but still viable tissue maintained by collateral circulation. The penumbra is the therapeutic target: if blood flow is restored promptly, these neurons can be salvaged; if not, they progressively recruit into the infarct core through a cascade of excitotoxicity, oxidative stress, and inflammation.

The Ischemic Cascade

When cerebral blood flow drops below approximately 10–12 mL/100g/min, cells in the infarct core undergo irreversible necrosis. In the penumbral zone, where flow ranges from roughly 12–22 mL/100g/min, neurons enter a state of electrical silence but remain structurally intact. Without reperfusion, the ischemic cascade proceeds: energy failure leads to loss of ion gradient maintenance, glutamate accumulation triggers calcium influx, and the resulting cytotoxic edema and free radical generation destroy cellular membranes. This cascade is why every 30-minute delay in reperfusion therapy reduces the probability of a good functional outcome by approximately 10–15%. For hemorrhagic stroke, the mechanism differs—rupture of a cerebral vessel causes direct parenchymal damage and mass effect from the hematoma, with secondary injury from perihematomal edema and inflammation—but the urgency is equally pressing.

Alteplase Dosing and Administration

ALTEPLASE TOTAL DOSE

TotalDose=0.9mg/kg×PatientWeight(kg)[Maximum:90mg]Total Dose = 0.9 mg/kg × Patient Weight (kg) [Maximum: 90 mg]

The total dose is divided into a 10% IV bolus administered over 1 minute, followed by the remaining 90% infused over 60 minutes. Accurate patient weight is critical; overestimation increases hemorrhage risk, and underestimation reduces efficacy.

BOLUS CALCULATION

Bolus=TotalDose×0.10Bolus = Total Dose × 0.10

For a 75 kg patient: Total = 0.9 × 75 = 67.5 mg; Bolus = 67.5 × 0.10 = 6.75 mg IV push over 1 minute; Infusion = 67.5 − 6.75 = 60.75 mg over 60 minutes.

⚠

Blood Pressure Parameters

Before alteplase: BP must be ≤ 185/110 mmHg. After alteplase: BP must be maintained ≤ 180/105 mmHg for 24 hours. IV labetalol, nicardipine, or clevidipine are commonly used. The nurse monitors BP every 15 minutes for the first 2 hours, then every 30 minutes for 6 hours, then hourly for 16 hours post-administration.

SECTION 5

Stroke Assessment Tools & Classification

Nurses employ several standardized assessment tools throughout the acute stroke continuum. Each tool serves a specific purpose—from prehospital screening to quantifying deficit severity to monitoring for deterioration. Mastery of these tools is essential both for clinical practice and for NCLEX questions, which frequently test the nurse's ability to select and apply the appropriate scale at the correct time.

STROKE ASSESSMENT TOOLS: WHEN TO USE EACHBE-FASTPublic / Prehospital ScreeningBalance difficultiesEye — vision changesFace droopingArm weaknessSpeech difficultyTime to call 911NIH STROKE SCALEED / Hospital Severity GradingScores 0 (normal) to 42 (max)Tests 11 domains:LOC, gaze, visual fields,facial palsy, motor arms/legs,ataxia, sensory, language,dysarthria, extinction/neglect0–5 mild6–1415+ severeGLASGOW COMA SCALEConsciousness MonitoringScores 3 (worst) to 15 (best)Eye Opening:1–4Verbal Response:1–5Motor Response:1–6GCS ≤8 = consider intubationUsed for ongoing monitoringSTROKE TYPE DIFFERENTIATIONISCHEMIC STROKE (~87%)• Thrombotic or embolic occlusion• CT: hypodense area (may be normal early)• Treatment: IV alteplase ± thrombectomy• Risk: A-fib, carotid stenosis, HTNCOREPenumbraClot blocks arteryPenumbra = salvageableThrombusHEMORRHAGIC STROKE (~13%)• Vessel rupture → bleeding into brain• CT: hyperdense (bright white) lesion• Treatment: BP control, reversal agents• Types: Intracerebral (ICH) / SubarachnoidBLEEDEdema zoneVessel ruptureMass effect + ICP ↑
Top row: Three key assessment tools used at different stages—BE-FAST for prehospital screening, the NIHSS for hospital severity grading, and the Glasgow Coma Scale for consciousness monitoring. Bottom row: Structural comparison of ischemic versus hemorrhagic stroke with key differentiating features.
FeatureIschemic StrokeHemorrhagic Stroke
Prevalence~87% of all strokes~13% of all strokes
CT AppearanceHypodense (dark); may be normal in first 6–12 hoursHyperdense (bright white) immediately visible
Primary TreatmentIV alteplase (rt-PA) ± mechanical thrombectomyBP control, anticoagulant reversal, possible surgical evacuation
BP Target Pre-Treatment≤ 185/110 mmHg (for alteplase eligibility)SBP < 140 mmHg (per AHA guidelines)
ThrombolyticsIndicated within 3–4.5 hr windowAbsolutely contraindicated
Key Risk FactorsAtrial fibrillation, carotid stenosis, hypercoagulabilityUncontrolled hypertension, AVM, aneurysm, anticoagulant use

Comparison of Ischemic vs. Hemorrhagic Stroke

SECTION 6

Worked Example: Managing an Acute Ischemic Stroke

The following scenario walks through the nurse's priority actions from patient arrival to thrombolytic administration, illustrating how the principles discussed above are applied in a time-pressured clinical environment.

Scenario: 68-Year-Old Male with Left-Sided Weakness

  1. 1

    Step 1 — Rapid Assessment and Stroke Code Activation

    A 68-year-old male arrives at the ED at 14:30 via EMS with right facial droop, left arm weakness, and slurred speech. His wife states symptoms began at 13:45. The nurse immediately performs ABCs—airway is patent, breathing adequate, circulation stable with BP 192/108 mmHg. The nurse recognizes these as classic stroke signs using the BE-FAST criteria and activates the stroke code. Two large-bore IV lines are established, blood is drawn for CBC, BMP, coagulation studies, and a point-of-care glucose is obtained: result 142 mg/dL (ruling out hypoglycemia as a stroke mimic).
    Stroke code activated. Time from door to stroke team notification: 4 minutes. Last known well: 13:45. Glucose: 142 mg/dL (normal).
  2. 2

    Step 2 — NIHSS Assessment and Emergent Imaging

    The stroke team neurologist and nurse collaboratively perform the NIHSS, scoring the patient at 14 (moderate-to-severe deficit: right facial droop = 2, left arm drift = 3, left leg drift = 3, dysarthria = 2, sensory loss = 1, language = 1, neglect = 2). The patient is immediately transported to CT at 14:38. The non-contrast CT head shows no evidence of hemorrhage and an early hyperdense MCA sign on the right side. CTA confirms a right M1 segment occlusion.
    NIHSS: 14. CT negative for hemorrhage. CTA: right M1 occlusion. Time from door to CT interpretation: 18 minutes.
  3. 3

    Step 3 — Alteplase Eligibility and BP Management

    The stroke neurologist reviews inclusion and exclusion criteria. Symptom onset was 45 minutes ago—well within the 4.5-hour alteplase window. However, BP is 192/108 mmHg, which exceeds the 185/110 threshold. The nurse administers IV labetalol 10 mg over 1–2 minutes. Repeat BP at 14:50 is 178/98 mmHg—now within the acceptable range. The patient has no exclusion criteria (no recent surgery, no known bleeding disorder, INR not elevated).
    BP controlled to 178/98 mmHg with labetalol. Patient meets all alteplase inclusion criteria.
  4. 4

    Step 4 — Alteplase Administration

    The patient weighs 82 kg. Using the dosing formula: Total dose = 0.9 mg/kg × 82 kg = 73.8 mg (under the 90 mg maximum). Bolus = 73.8 × 0.10 = 7.38 mg IV push over 1 minute. Remaining infusion = 73.8 − 7.38 = 66.42 mg over 60 minutes. The nurse verifies the dose with a second RN, administers the bolus at 14:55, and initiates the infusion. All invasive procedures (Foley, NG tube, arterial lines) are completed before the bolus or deferred until after the 24-hour post-alteplase period.
    Door-to-needle time: 25 minutes (well under the 60-minute target). Alteplase infusion running. Neuro checks initiated every 15 minutes.
  5. 5

    Step 5 — Post-Alteplase Monitoring and Thrombectomy Referral

    The nurse monitors for signs of hemorrhagic conversion: any new headache, acute hypertension, nausea/vomiting, or neurological decline triggers immediate cessation of the alteplase infusion and a STAT repeat CT. BP is maintained ≤ 180/105 mmHg. Given the large-vessel occlusion (right M1), the patient is simultaneously being prepared for mechanical thrombectomy by the neurointerventional team. No antiplatelets or anticoagulants will be administered for 24 hours. A formal dysphagia screen will be performed before any oral intake.
    Patient stable, NIHSS reassessed at 15:15 → score improved from 14 to 10. Thrombectomy planned for recanalization of the M1 occlusion. Full neuroprotective nursing measures in place.

SECTION 7

Nursing Considerations, Strengths & Limitations

While the acute stroke care framework is highly effective when executed properly, nurses must understand both the strengths of current protocols and the limitations that can affect patient outcomes. Recognizing these factors prepares nurses to advocate for their patients, troubleshoot common barriers, and anticipate complications that arise in real-world clinical settings.

Strengths of Current ProtocolsLimitations & Challenges
Evidence-based door-to-needle benchmarks have reduced treatment delays significantly since the 1990sOnly ~3–5% of ischemic stroke patients actually receive alteplase, often due to delayed presentation or unrecognized symptoms
Standardized assessment tools (NIHSS, BE-FAST) enable reproducible, rapid evaluation across providersStroke mimics (hypoglycemia, seizures, migraines) can consume valuable time and resources during differential diagnosis
Extended time windows (thrombectomy up to 24 hr) have dramatically expanded the eligible patient populationThrombectomy requires specialized neurointerventional capability not available at all hospitals; transfer adds delay
Telestroke technology allows neurologist consultation for rural and underserved facilitiesHemorrhagic stroke has no equivalent to alteplase—treatment is primarily supportive and surgical, with higher mortality
Multidisciplinary stroke teams improve coordination and reduce errors during the acute phasePatient factors—unclear last known well time, anticoagulant use, recent surgery—may disqualify otherwise eligible patients from thrombolysis

Strengths and Limitations of Acute Stroke Care Protocols

🧠

CLINICAL CONTEXT

On the NCLEX-RN, questions about acute stroke will test your ability to prioritize actions in a specific clinical scenario. Remember that the correct answer almost always reflects the principle of "What saves the most brain tissue fastest?" This means activating the stroke code before completing a full history, obtaining CT before administering any treatment, and checking only glucose before alteplase—not waiting for the complete metabolic panel. When in doubt, think about what action moves the patient closest to definitive treatment in the shortest time.

SECTION 8

Connection to Advanced Stroke Management

The foundational principles of acute stroke care connect directly to advanced concepts that nursing students will encounter in critical care, neuroscience nursing, and advanced practice roles. Understanding these connections deepens comprehension of why acute-phase decisions have such profound downstream effects on rehabilitation potential and long-term outcomes.

Acute Phase ConceptAdvanced Application
Door-to-needle time (IV alteplase within 60 min)Door-to-device time for thrombectomy; perfusion imaging (CTP) to identify penumbral mismatch for extended window patients
NIHSS severity scoring (0–42)Modified Rankin Scale (mRS) for long-term functional outcome measurement; NIHSS trending to detect early neurological deterioration
BP management per protocol thresholdsAutoregulation-guided BP management in the ICU; continuous arterial monitoring; permissive hypertension vs. strict control debate
Dysphagia screening before oral intakeFormal videofluoroscopic swallow study (VFSS); aspiration pneumonia prevention protocols; early rehabilitation initiation
ICP monitoring in hemorrhagic strokeExternal ventricular drain (EVD) management; cerebral perfusion pressure (CPP) optimization; decompressive craniectomy decision-making

Bridging Acute Stroke Care to Advanced Practice

As you progress from foundational nursing into specialty practice, the principles you learn in acute stroke care—rapid assessment, protocol-driven decision-making, and physiological optimization—will serve as templates for managing other time-sensitive emergencies, including STEMI protocols, sepsis bundles, and trauma resuscitation. The NCLEX-RN tests your understanding of these foundational competencies, but the clinical reasoning skills they build will define your effectiveness throughout your career.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A nursing student asks why the phrase "time is brain" is central to stroke care. Explain the physiological basis for this statement, specifically addressing the relationship between the infarct core, the ischemic penumbra, and the time course of neuronal death in untreated large-vessel ischemic stroke.
Show answer
The phrase "time is brain" reflects the fact that approximately 1.9 million neurons die every minute during an untreated large-vessel ischemic stroke. The infarct core represents tissue that has already undergone irreversible necrosis due to complete ischemia. Surrounding it, the ischemic penumbra is hypoperfused but maintained by collateral blood flow—these neurons are electrically silent but structurally intact and can be salvaged if reperfusion occurs promptly. Without treatment, the ischemic cascade (energy failure → glutamate excitotoxicity → calcium influx → cytotoxic edema → cell death) progressively converts penumbral tissue into infarct. Every 30-minute delay in reperfusion reduces the probability of a favorable functional outcome by approximately 10–15%, making rapid intervention the single greatest determinant of neurological recovery.

Question 2: BASIC CALCULATION

A 70 kg patient is eligible for IV alteplase. Calculate the total dose, the bolus dose, and the infusion dose. Describe how each component is administered.
Show answer
Using the formula Total Dose = 0.9 mg/kg × body weight: Total = 0.9 × 70 = 63 mg (well under the 90 mg maximum). The bolus is 10% of the total: 63 × 0.10 = 6.3 mg administered IV push over 1 minute. The remaining 90% is the infusion: 63 − 6.3 = 56.7 mg infused over 60 minutes. The bolus provides an immediate therapeutic blood level while the infusion maintains it. The nurse must verify the dose with a second RN, ensure accurate patient weight, and monitor vital signs and neurological status every 15 minutes during the infusion.

Question 3: INTERMEDIATE

A patient arrives at the ED with sudden-onset right hemiparesis and aphasia. Last known well time was 2 hours ago. Initial BP is 198/114 mmHg. The non-contrast CT head is negative for hemorrhage. The nurse prepares to administer alteplase but recognizes the BP exceeds the threshold. What is the nurse's priority action, and what is the BP target that must be achieved before alteplase can be administered?
Show answer
The nurse's priority action is to administer an antihypertensive agent, most commonly IV labetalol 10–20 mg over 1–2 minutes or initiate an IV nicardipine drip at 5 mg/hr (titrate up by 2.5 mg/hr every 5–15 minutes). The BP must be reduced to ≤ 185/110 mmHg before alteplase can be administered. If BP does not respond to two doses of labetalol (or equivalent), the patient may not be a candidate for thrombolysis. This is critical because administering alteplase at hypertensive levels significantly increases the risk of hemorrhagic transformation. After alteplase is given, the BP target becomes ≤ 180/105 mmHg for 24 hours.

Question 4: APPLIED

During an alteplase infusion for acute ischemic stroke, the patient develops a sudden severe headache, acute increase in BP to 210/120 mmHg, and new right pupil dilation. NIHSS increases from 12 to 22. Identify the most likely complication, state the nurse's immediate priority actions in sequence, and explain the rationale for each.
Show answer
The presentation—sudden headache, acute hypertension, pupil change, and neurological deterioration during alteplase infusion—is classic for hemorrhagic transformation (intracranial hemorrhage), the most feared complication of thrombolytic therapy. The nurse must: (1) Immediately stop the alteplase infusion to prevent further bleeding; (2) Notify the stroke team/neurologist STAT; (3) Obtain a STAT non-contrast CT head to confirm hemorrhage; (4) Draw labs including fibrinogen, PT/INR, and type and screen; (5) Prepare for possible cryoprecipitate administration (if fibrinogen < 200 mg/dL) and tranexamic acid per protocol. The pupil dilation suggests uncal herniation from mass effect, and the patient may require emergent neurosurgical intervention.

Question 5: CRITICAL THINKING

A 55-year-old woman presents with acute left-sided weakness and neglect. Her husband reports she was "fine at dinner last night at 20:00" but found her symptomatic upon waking at 06:30. Her NIHSS is 18 and CT shows no hemorrhage. CTA reveals a left M1 occlusion. The 4.5-hour alteplase window has passed based on last known well time. Discuss what treatment options remain available, the imaging that may expand her eligibility, and the nurse's role in facilitating this pathway.
Show answer
This patient presents with a wake-up stroke, where the last known well time is 20:00—over 10 hours ago—placing her outside the standard alteplase window. However, two critical pathways remain. First, based on the DAWN and DEFUSE 3 trials, mechanical thrombectomy can be performed up to 24 hours from last known well for large-vessel occlusions (which her M1 occlusion qualifies) if CT perfusion (CTP) or MRI diffusion-perfusion imaging demonstrates a favorable mismatch—meaning there is a significant volume of salvageable penumbral tissue relative to the infarct core. Second, the WAKE-UP trial demonstrated that DWI-FLAIR mismatch on MRI can identify patients who may benefit from alteplase even with unknown onset time. The nurse's role includes ensuring rapid CTP or MRI acquisition, communicating with the neurointerventional team, maintaining the patient NPO, managing BP per protocol, and preparing for possible transfer to a comprehensive stroke center if thrombectomy-capable services are not available on-site.

SUMMARY

Acute Stroke Care: Summary Review

Summary

Acute stroke management is defined by the principle that time is brain—approximately 1.9 million neurons are lost every untreated minute. The nurse's priority actions begin with ABCs and stroke code activation within the first 10 minutes, followed by rapid NIHSS assessment and emergent non-contrast CT imaging to differentiate ischemic from hemorrhagic stroke. For ischemic stroke, IV alteplase (0.9 mg/kg, max 90 mg) is administered within a 3–4.5 hour window, with a door-to-needle target of ≤ 60 minutes. Only blood glucose must result before alteplase can be given. Blood pressure must be ≤ 185/110 pre-treatment and ≤ 180/105 post-treatment.

For hemorrhagic stroke, thrombolytics are absolutely contraindicated—management focuses on aggressive BP control (SBP < 140), anticoagulant reversal, and possible surgical evacuation. Mechanical thrombectomy extends the treatment window up to 24 hours for large-vessel occlusions with favorable perfusion imaging. Critical nursing actions across all stroke types include neurological monitoring every 15 minutes, dysphagia screening before oral intake, maintaining NPO status until swallowing safety is confirmed, and holding all antiplatelets and anticoagulants for 24 hours post-alteplase. Any neurological decline during thrombolytic infusion mandates immediate cessation of alteplase and STAT CT to evaluate for hemorrhagic transformation.

Varsity Tutors • NCLEX-RN • Acute Stroke: Priority Actions And Care — Acute Stroke: Priority Actions And Time-Sensitive Care